Forty Seven Inc (NASDAQ:FTSV) insider Chris H. Takimoto sold 8,000 shares of the company’s stock in a transaction on Friday, May 3rd. The shares were sold at an average price of $17.99, for a total value of $143,920.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link.
Shares of Forty Seven stock opened at $18.65 on Friday. Forty Seven Inc has a 52 week low of $12.02 and a 52 week high of $23.83. The firm has a market capitalization of $584.85 million and a PE ratio of -4.97.
Forty Seven (NASDAQ:FTSV) last announced its quarterly earnings results on Thursday, March 28th. The company reported ($0.56) EPS for the quarter, beating the Thomson Reuters’ consensus estimate of ($0.66) by $0.10. Sell-side analysts expect that Forty Seven Inc will post -2.61 earnings per share for the current year.
Several analysts have issued reports on FTSV shares. Oppenheimer set a $35.00 target price on Forty Seven and gave the company a “buy” rating in a report on Friday, January 11th. HC Wainwright restated a “buy” rating and issued a $21.00 target price on shares of Forty Seven in a report on Monday, January 14th. Zacks Investment Research cut Forty Seven from a “hold” rating to a “sell” rating in a report on Tuesday, January 15th. FIG Partners assumed coverage on Forty Seven in a report on Friday, February 1st. They issued a “buy” rating and a $30.00 target price for the company. Finally, Guggenheim assumed coverage on Forty Seven in a research note on Friday, April 12th. They issued a “buy” rating on the stock. One analyst has rated the stock with a hold rating and nine have issued a buy rating to the stock. The company has a consensus rating of “Buy” and a consensus price target of $26.75.
COPYRIGHT VIOLATION NOTICE: “Forty Seven Inc (FTSV) Insider Chris H. Takimoto Sells 8,000 Shares” was first reported by Baseball Daily News and is owned by of Baseball Daily News. If you are reading this piece of content on another publication, it was illegally stolen and republished in violation of United States & international trademark and copyright legislation. The correct version of this piece of content can be read at https://www.baseballdailydigest.com/news/2019/05/10/forty-seven-inc-ftsv-insider-chris-h-takimoto-sells-8000-shares.html.
About Forty Seven
Forty Seven Inc, a clinical-stage immuno-oncology company, focuses on developing therapies to activate macrophages for the treatment of cancer. It is developing 5F9, a humanized IgG4 subclass monoclonal antibody against CD47 that is in Phase 1b/2 clinical trials used for the treatment of cancer; FSI-189, an antibody that binds to SIRPa; and FSI-174, an anti-cKIT antibody.
Read More: Why do company’s buyback their stock?
Receive News & Ratings for Forty Seven Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Forty Seven and related companies with MarketBeat.com's FREE daily email newsletter.